コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ine, thiazole, quinoxaline, benzoxazole, and quinolone.
2 ) to form the signal molecule 2-heptyl-4(1H)-quinolone.
3 pare patients treated with azithromycin vs a quinolone.
4 which makes this enzyme produce the diketide quinolone.
5 to pyridyl 4,5-dihydro-[1,2,4]triazolo[4,3-a]quinolones.
6 a promoter for the synthesis of substituted quinolones.
7 d tetrahydroquinolines to afford indoles and quinolones.
8 and parC recognized to confer resistance to quinolones.
9 addition, 13 (44.8%) of 29 patients received quinolones.
10 ins (four cases), cephalosporins (41 cases), quinolones (15 cases), and pristinamycin (seven cases) w
11 ent publications report in vitro activity of quinolone 3-esters against the bc1 protein complex of Pl
13 roperties of previously reported 4-hydroxy-2-quinolone-3-carboxamides, a structural optimization prog
16 nd in-house screening of a limited number of quinolones (50 compounds) identified approximately 100 h
17 d out to downselect the most promising 4(1H)-quinolones, 7, 62, 66, and 67, which possessed low-nanom
20 olin: adjusted OR = 0.49; 95% CI, 0.34-0.71; quinolone: adjusted OR = 0.55; 95% CI, 0.35-0.87) for co
28 r the anthranilate-derived production of the quinolone and acridone alkaloid by type III polyketide s
29 thaliana and that the plant is sensitive to quinolone and aminocoumarin antibiotics, compounds that
31 ions is a two-point hydrogen bonding between quinolone and catalyst enabling efficient energy transfe
33 ruginosa PAO1-based 2-heptyl-3-hydroxy-4(1H)-quinolone and N-(3-oxododecanoyl)-l-homoserine lactone r
34 ing (QS) molecules, 2-heptyl-3-hydroxy-4(1H)-quinolone and N-(3-oxododecanoyl)-l-homoserine lactone,
35 d to compare the rate of perforation between quinolone and neomycin plus hydrocortisone ear drop-expo
39 ated with resistance to isoniazid, rifampin, quinolones and injectable drugs in Mycobacterium tubercu
40 vel class of N-linked aminopiperidinyl alkyl quinolones and naphthyridones that kills Mtb by inhibiti
42 racis topoisomerase IV, their sensitivity to quinolones and related drugs and their use of metal ions
43 l molecules including Pseudomonas-associated quinolones and rhamnolipids in feces, setting the stage
44 t-off values of beta-lactams, tetracyclines, quinolones and sulfonamides were determined to be 8 ng/m
45 ansport-kinetics of antimicrobial drug ions (quinolones and sulfonamides) at a water/oil interface.
48 for interactions between clinically relevant quinolones and topoisomerase IV and provide a likely mec
49 decreased development of new cephalosporin, quinolone, and macrolide drugs and reduced participation
50 d chromones, as well as a thiochromone and a quinolone, and the resulting vinylogous addition product
51 ng/mL for tetracyclines, 0.08-2.0 ng/mL for quinolones, and 0.1-3.98 ng/mL for sulfonamides, with li
54 -level susceptibility to most macrolides and quinolones, and moderate susceptibility to most tetracyc
57 and microbiological evaluation of chromone-, quinolone-, and benzoxazinone-3-sulfonamide derivatives
61 this study, the adsorption of a widely used quinolone antibiotic in aquaculture, Oxolinic acid (OA),
64 that the reactive transport of a widely used quinolone antibiotic, pipemidic acid (PIP), in MnO(2)-co
67 Since their discovery over 5 decades ago, quinolone antibiotics have found enormous success as bro
68 raphic method for the determination of seven quinolone antibiotics in tissue of Atlantic salmon (Salm
69 s the capacity of magnetite to bind not only quinolone antibiotics such as nalidixic acid (NA) and fl
71 ation of Escherichia coli persisters against quinolone antibiotics which target the GyrA subunit of D
74 nes were shown to sensitize P. aeruginosa to quinolones, antibiotics that elicit a strong SOS respons
79 ated mutations [MRMs]) and in parC and gyrA (quinolone-associated mutations) were detected by targete
82 llographic and biochemical studies show that quinolone binding involves a water/metal-ion bridge betw
84 raphy reveals that 34 occupies the classical quinolone binding site in the topoisomerase IV-DNA cleav
85 he data support the existence of a secondary quinolone-binding mode in which the quinolone C7 ring sy
86 ificities and produces not only acridone and quinolone but also chalcone, benzophenone, and phloroglu
87 nvolves a water/metal-ion bridge between the quinolone C3-C4 keto-acid and amino acids in helix-4 of
88 econdary quinolone-binding mode in which the quinolone C7 ring system interacts with GyrA; the data a
89 ether the infected strains were resistant to quinolone can be performed simultaneously on a single ch
90 completely restored by treatment with benzyl quinolone carboxylic acid (BQCA) and benzoquinazoline-12
92 ated the actions at an M(1) DREADD of benzyl quinolone carboxylic acid (BQCA), a positive allosteric
93 ently described allosteric modulator, benzyl quinolone carboxylic acid (BQCA), behaves according to a
94 sclosures of an independent discovery of the quinolone class of antibacterials have been almost entir
97 cepts point to new approaches for developing quinolone-class compounds that have increased potency ag
98 up other than the commonly used pyridine and quinolone classes for Cp*Co(III) -catalyzed C(sp(3) )-H
102 itution pattern on the benzenoid ring of the quinolone core significantly influenced reactivity with
104 give ring-fused indoles B, quinolines C, or quinolones D depending on the reaction conditions employ
106 The 6-amino-7-[4-(2-pyridinyl)-1-piperazinyl]quinolone derivative 8 proved to be the best compound of
107 ty of vosaroxin, a first-in-class anticancer quinolone derivative, plus cytarabine in patients with r
115 nt SIMS imaging at the same location detects quinolone distributions in excellent agreement with the
117 that an A. thaliana mutant resistant to the quinolone drug ciprofloxacin has a point mutation in ATG
118 argeted DNA gyrase that is the target of the quinolone drug ciprofloxacin; this has important consequ
127 ification, resulting in metabolically stable quinolones effective against multi drug resistant (MDR)
131 cs, beta-lactam (ampicillin and penicillin), quinolone (enoxacin), aminoglycoside (kanamycin and neom
132 g modes raises the possibility that multiple quinolone-enzyme-DNA complexes can form, a discovery tha
133 preliminary structural optimization of 4(1H)-quinolone ester derivatives, a new series of antimalaria
136 ructure-activity relationship study on 4(1H)-quinolones, focusing on the reduction of cross-resistanc
138 tween the lowest energy hydroxyquinoline and quinolone forms is 27 and 38 kJ mol(-1), for 5Me-HQE and
139 ence for the preparation of functionalized 4-quinolones from 2-iodoanilines and alkynes via two diffe
142 tivity of some aryl propionic acids, (fluoro)quinolones, furocoumarins, metal coordination complexes,
144 ns are novel fungal alkaloids that feature a quinolone-gamma-lactam hybrid, which is a potential phar
145 panding the paradigm for the biosynthesis of quinolone-gamma-lactam natural products via Dieckmann co
149 isolates were found to be susceptible to the quinolone group of antibiotics (moxifloxacin followed by
152 ely used to treat bacterial infections, some quinolones have unexplained side effects, including deat
153 ne known inhibitor, hydroxy-2-dodecyl-4-(1H)-quinolone (HDQ), and this was used along with a range of
154 rther demonstrated in synthesis of quinoline-quinolone hybrid as well as 6-aryl-benzofuro[3,2-c]quino
161 nfection among isolates usually sensitive to quinolones in the levofloxacin group vs placebo (14/24 [
163 +) concentration required to produce maximal quinolone-induced DNA cleavage and restricted the divale
166 s are proposed to serve as a critical enzyme-quinolone interaction site by anchoring a water-metal io
167 water-metal ion bridge that is critical for quinolone interactions with other bacterial type II topo
169 ermination of 2-amino-3-methyl imidazo[4-5-f]quinolone (IQ), 2-amino-3, 8-dimethlylimidazo[4, 5-f]qui
171 quinolone signal (PQS; 2-heptyl-3-hydroxy-4-quinolone) is one of these signals, and it is known to b
172 sing resistance to multiple drugs, including quinolones, is associated with decreased susceptibility
174 quent Mtb screening of the complete in-house quinolone library (350 compounds) identified a further a
175 e (IQ), 2-amino-3, 8-dimethlylimidazo[4, 5-f]quinolone (MeIQ), 2-amino-3,4- dimethylimidazo[4,5-f]qui
176 ity, and suggest that re-engineering certain quinolones might help develop newer antibacterials.
177 and it controls the production of 2-alkyl-4-quinolone molecules which are important for pathogenicit
179 for isoniazid, 98.7% for rifampin, 97.6% for quinolones (ofloxacin, levofloxacin, or moxifloxacin), 9
180 n carboxylate or amide group of deprotonated quinolone or sulfonamide, respectively, may play a domin
183 m beta-lactamase-producing type SHV-12), and quinolones (plasmid-mediated quinolone resistance gene q
185 QS signal molecule 2-heptyl-3-hydroxy-4(1H)-quinolone (PQS), a minimal medium containing PQS as the
188 nones with 2-formyl azaarenes (pyridines and quinolones) provides azaaryl (pyridyl and quinolyl) auro
189 The small molecule 2-heptyl-3-hydroxy-4-quinolone (Pseudomonas Quinolone Signal [PQS]) is one of
192 s related to an impaired production of alkyl quinolone QS signals, likely prompted by the reduced ava
193 anese oxides used as engineered geomedia for quinolone remediation and in developing transport models
195 he topoisomerase genes, but plasmid-mediated quinolone resistance (PMQR) mechanisms have also been de
196 gyrB, parC, and parE and/or plasmid-mediated quinolone resistance (PMQR) mechanisms including qnr var
197 d for Escherichia coli with plasmid-mediated quinolone resistance (PMQR), extended-spectrum beta-lact
198 industrial region in India were analyzed for quinolone resistance (qnr) genes by quantitative PCR.
201 the findings will inform the development of quinolone resistance assays needed to ensure optimal sel
202 t mutations at GyrA(A90) and GyrA(D94) cause quinolone resistance by disrupting the bridge-enzyme int
203 y by target-based mutations in the GyrA/ParC quinolone resistance determining region, have eroded the
212 re unlikely to exist in nature; nonetheless, quinolone resistance proteins have been identified.
218 timicrobial resistance genes and mutation in quinolone resistance-determining regions (QRDR) in fecal
220 lmonella due to chromosomal mutations in the quinolone resistance-determining regions (QRDRs) of the
228 ked to increased risk of community-acquired, quinolone-resistant bacteria in their offspring, by abou
229 nked to increased risk of community-acquired quinolone-resistant bacteria in their offspring, by abou
233 istant gram-negative bacteria (P = .016), or quinolone-resistant gram-negative bacteria (QR-GNB) (P =
234 bacteriostatic activity for Cip-AcCl with a quinolone-resistant GyrA-G81C variant of Escherichia col
235 nother multivariate analysis performed among quinolone-resistant isolates, treatment failure was 3 ti
239 Acinetobacter baumannii [8], carbapenem- and quinolone-resistant Pseudomonas aeruginosa [26], and der
240 inst most Gram-positive pathogens, including quinolone-resistant strains, which is further enhanced a
243 he general 6-chloro-7-methoxy-2-methyl-4(1H)-quinolone scaffold which were substituted at the 3-posit
244 ive antimalarial pharmacophores, such as the quinolone scaffold, to yield potent and highly efficacio
245 een appended to the C7 position of different quinolone scaffolds do not take advantage of specific co
246 e envisioned, and then created, novel 4-(1H)-quinolone scaffolds that target the cytochrome bc1 compl
248 Moreover we show that, as in bacteria, the quinolone-sensitive (wild-type) allele is dominant to th
250 Extensive physicochemical evaluation of the quinolone series was carried out to downselect the most
251 by P. aeruginosa and whether the Pseudomonas quinolone signal (PQS) and the MucD periplasmic protease
254 regulator) for its regulation of Pseudomonas quinolone signal (PQS) production and anthranilate metab
256 nteracting with the iron-binding Pseudomonas quinolone signal (PQS), a cell-cell signalling compound.
257 so promote the production of the Pseudomonas quinolone signal (PQS), a quorum sensing molecule that a
258 ced secreted small molecule, the Pseudomonas quinolone signal (PQS), has been shown to initiate OMV f
261 2-heptyl-3-hydroxy-4-quinolone (Pseudomonas Quinolone Signal [PQS]) is one of these signals and its
263 h as the quorum-sensing molecule Pseudomonas quinolone signal and the exopolysaccharide Psl, is regul
264 qsR acts as the receptor for the Pseudomonas quinolone signal, and it controls the production of 2-al
265 cteristic fatty acids (e.g., palmitic acid), quinolone signal, and riboflavin fragments were found to
266 timulation by denatonium or with Pseudomonas quinolone signaling molecules led to an increase in muco
267 ins, carbohydrates, and, for the first time, quinolone signaling molecules-in Pseudomonas-derived bio
268 nt agreement with the CRM, discerns multiple quinolone species which differ slightly in mass, resolve
271 nd, shifting from 4-quinolone to 4-hydroxy-2-quinolone structure enabled the discovery of a novel cla
275 lones, macrolides, nitrofurans, penicillins, quinolones, sulfamides and tetracyclines) in Argentinean
276 actam, imidazole, macrolide, nitrofurantoin, quinolone, sulphonamide and trimethoprim, and tetracycli
278 Two novel type III polyketide synthases, quinolone synthase (QNS) and acridone synthase (ACS), we
279 ion of a novel Type III polyketide synthase, quinolone synthase (QNS), from A. marmelos that is invol
280 identification of a characteristic FabH-like quinolone synthase from Pseudomonas aeruginosa with high
282 tic elements and resistance determinants for quinolones, tetracyclines, and beta-lactamases are share
283 g-binding mode in which the other end of the quinolone, the C7 ring system, interacts with GyrA.
284 the critically important antimicrobials were quinolones, third- and fourth-generation cephalosporins,
286 raoxonase 2 (PON2) inhibitor (Triazolo[4,3-a]quinolone, TQ416) significantly affected recovering cell
288 is study investigated the effect of maternal quinolone use on gram-negative bacterial resistance to q
290 S data and further show that the anti-cancer quinolone vosaroxin acts solely as an intercalating pois
291 95% confidence interval [CI], 5.0%-8.2%) for quinolones vs 6.4% (95% CI, 5.0%-7.9%) for azithromycin
292 dium berghei in mice showed that these 4(1H)-quinolones were efficacious for the reduction of parasit
298 dary metabolites, including rhamnolipids and quinolones, were detected and visualized on both macro-
299 The biological evaluation illustrated that 4-quinolones with a benzylamide function in position 3 and
300 lected aptamers were shown to detect various quinolones with high specificity, while specific binding